Fungal Superbug as Public‑Health Priority

CDC data show Candida auris caused at least 7,000 U.S. infections in 2025 across 27 states and is spreading globally, with some strains resistant to existing antifungal classes. This elevates invasive fungal threats into frontline preparedness: hospitals need stronger infection control and surveillance, regulators must accelerate antifungal approval and trials, and agencies must coordinate rapid data sharing. — Recognizing drug‑resistant fungi as a national preparedness priority shifts funding, surveillance design, hospital protocols, and R&D incentives with consequences for patient safety and health‑system resilience.